The Medications · May 20, 2026 · 5 min · By Lorenzo Adeyinka
GLP-1 dose titration: why you start low and go slow
The step-up schedule is not bureaucracy. It is how your gut learns to tolerate the medication.

If you start a GLP-1 medication, you do not begin at the dose that produces the most weight loss. You begin at a small dose that may do almost nothing to your appetite, and you climb in steps over weeks or months. New patients often find this frustrating, especially when they are paying out of pocket and want results. The slow start is not bureaucracy. It is the single best tool for keeping you on the medication long enough to benefit.
Why starting low matters
The most common side effects of these drugs are gastrointestinal: nausea, vomiting, diarrhea, and constipation. They are usually worst when the dose changes and they tend to ease as your body adapts. Starting low and increasing gradually gives your gut time to adjust at each step, which keeps the side effects manageable. Jump too fast and you are far more likely to feel miserable, and people who feel miserable stop taking the drug. The Mayo Clinic describes semaglutide as a medication that is deliberately increased in stages for exactly this reason.
What a typical schedule looks like
For once-weekly semaglutide approved for weight management, the standard approach is a starting dose held for about four weeks, then a series of increases roughly every four weeks until reaching a maintenance dose. The FDA-approved labeling lays out this stepwise escalation. Tirzepatide follows its own multi-step schedule. The exact milligram numbers differ by drug and by whether the prescription is for weight or for diabetes, so the schedule on your pen is the one that matters, not a number you saw online.
The dose is not a race
A common misunderstanding is that the highest dose is the goal and anything less is failure. It is not. The goal is the lowest dose that gives you good results with tolerable side effects. Plenty of people lose weight well on a middle dose and never need the maximum. If you are doing fine where you are, there is rarely a reason to keep climbing just to reach the top of the chart.
Slowing down or pausing
If side effects flare when you step up, the schedule is not set in stone. Clinicians often hold a patient at the current dose for an extra few weeks, or even step back down temporarily, before trying to advance again. This is normal and it is not a setback. It is the system working as intended. The same applies if life gets in the way: a stomach bug or a stretch of poor eating can make a dose increase a bad idea that week. The medication will still be there next week.
Missed doses have their own rules. A short gap can often be made up, but a longer gap sometimes means restarting lower so your gut readjusts safely. That is a question for your prescriber rather than a guess, because restarting at a high dose after time off can bring the nausea roaring back.
Managing the bumps
Much of what makes titration tolerable is simple. Eat smaller portions, stop when you feel full rather than when the plate is clear, go easy on greasy and very rich foods, and stay hydrated. These habits blunt the nausea that tends to accompany each step up. Our guide to managing GLP-1 nausea goes into the practical tactics in detail.
The takeaway
Think of titration as training, not waiting. The slow climb is how your body learns to tolerate a powerful medication, and rushing it usually backfires into side effects severe enough to make you quit. Follow the schedule your clinician sets, speak up early when a step is rough so the plan can be adjusted, and remember that the best dose is the one that works for you with side effects you can live with, not the biggest number available. This is general information and not a substitute for your prescriber's instructions. If you are still deciding between options, our comparison of semaglutide versus tirzepatide is a good next stop.
Related reading: Managing GLP-1 nausea.